AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Heidelberg Pharma AG

Declaration of Voting Results & Voting Rights Announcements Aug 12, 2010

201_dva_2010-08-12_4d2426de-f47b-4111-a10a-52c8d1a17488.html

Declaration of Voting Results & Voting Rights Announcements

Open in Viewer

Opens in native device viewer

News Details

Voting Rights Announcements | 12 August 2010 18:18

WILEX AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

WILEX AG / Release of an announcement according to Article 21 Section 1a of the WpHG (Report on first admission of shares)

12.08.2010 18:18

Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.


On August 12, 2010, The Merlin Biosciences Fund L.P., St. Helier, Jersey,
Channel Islands, has informed us according to Article 21, Section 1a of the
WpHG that its Voting Rights on WILEX AG, Munich, Germany, ISIN:
DE0006614720, amounted on November 10, 2006 6.73% (this corresponds to
804,975 Voting Rights).

12.08.2010 Ad hoc announcement, Financial News and Press Release distributed by DGAP.
Media archive at www.dgap-medientreff.de and www.dgap.de


Language: English
Company: WILEX AG
Grillparzerstr. 10
81675 München
Deutschland
Internet: www.wilex.com

End of News DGAP News-Service


Talk to a Data Expert

Have a question? We'll get back to you promptly.